Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.

@article{Sigal1987PrototypeQA,
  title={Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.},
  author={Samuel H Sigal and George Cembrowski and Sanford J Shattil and Nicholas M. Brown and Robert Schifreen and Michael W. Schwartz},
  journal={Archives of internal medicine},
  year={1987},
  volume={147 10},
  pages={
          1790-3
        }
}
A new quantitative assay for fibrinogen/fibrin degradation products (FDPs) was clinically evaluated in 123 tertiary-care patients for whom the standard semiquantitative FDP assay had previously been ordered. On the basis of a comprehensive chart review, 24 patients were categorized as having disseminated intravascular coagulation (DIC), 84 were considered not to have had DIC, ten had fibrinolysis (nine of ten streptokinase induced), and five had a complicated coagulopathy whose exact nature… CONTINUE READING